I Peace, Inc. ( specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the next generation iPS cell mass-manufacturing automated system (EGG) the ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

Stem-cell derived organoids provide the perfect mixture of cells to rebuild damaged intestines.

Imagine standing in front of a gentle giant whose kind once roamed vast African plains in great numbers, only to realize you ...

Researchers have developed a method to extract living cells from feces that they say could help conservationists better ...

Cellistic has launched the Echo-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target ...

Cellistic introduces Echo-NK Platform to enable scalable manufacturing of allogeneic cell therapies to target multiple diseases: Mont-Saint-Guibert, Belgium Monday, April 14, 2025 ...

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and other neurological disorders, according to University of California, Irvine ...

the team successfully obtained iPSC clones. “The clones were very beautiful. We were so excited,” Liu reminisced. The team then confirmed that the iPSCs that they had identified based on physical ...

Cellistic, a pioneer in induced pluripotent stem cells (iPSC)-based cell therapies, is launching the Echo™-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target ...

Keio University doctors said they have taken a promising step toward using human induced pluripotent stem (iPS) cells to treat spinal cord injuries.